(Q53416070)

14 May 2018

title

In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. (English)

1 reference

14 May 2018

1 reference

13

1 reference

14 May 2018

Katsuaki Suzuki

14

1 reference

14 May 2018

Yasuhide Iwata

11

Yasuhide Iwata

1 reference

14 May 2018

Genichi Sugihara

8

Genichi Sugihara

1 reference

14 May 2018

Shiro Suda

10

Shiro Suda

1 reference

14 May 2018

Tomoyasu Wakuda

7

Tomoyasu Wakuda

1 reference

14 May 2018

Takatoshi Ueki

12

Takatoshi Ueki

1 reference

14 May 2018

Kazuhiko Nakamura

15

Kazuhiko Nakamura

1 reference

14 May 2018

Kiyokazu Takebayashi

9

Kiyokazu Takebayashi

1 reference

14 May 2018

Yasuomi Ouchi

16

Yasuomi Ouchi

1 reference

14 May 2018

Mitsuru Kikuchi

5

Mitsuru Kikuchi

1 reference

14 May 2018

Etsuji Yoshikawa

4

Etsuji Yoshikawa

1 reference

14 May 2018

Yujiro Yoshihara

6

Yujiro Yoshihara

1 reference

14 May 2018

author name string

Masamichi Yokokura

1

1 reference

14 May 2018

Norio Mori

2

1 reference

14 May 2018

Shunsuke Yagi

3

1 reference

14 May 2018

publication date

16 September 2010

1 reference

14 May 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

14 May 2018

volume

38

1 reference

14 May 2018

page(s)

343-351

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-010-1612-0

exact match

0 references

cites work

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Role of toll-like receptor signalling in Abeta uptake and clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

In-vivo measurement of activated microglia in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Altered glucose metabolism in the hippocampal head in memory impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Microglial activation and dopamine terminal loss in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Anti-inflammatory drugs and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Postmortem studies of the effect of anti-inflammatory drugs on Alzheimer-type pathology and associated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1612-0

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis

21 January 2018

1 reference

12 December 2020

Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway

1 reference

12 December 2020

Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography.

1 reference

12 December 2020

Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

1 reference

12 December 2020

The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity

1 reference

12 December 2020

10.1007/S00259-010-1612-0

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

20844871

1 reference

14 May 2018